OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
IVN50

Ivision Tech SpA

Medical Equipment, Supplies & DistributionVerified

Ivision Tech SpA has a fully diluted share count of 7,912,406 shares, with no difference between basic and diluted shares outstanding, indicating no dilution from stock options or convertible securities. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability and return metrics are not available for Ivision Tech SpA, as the valuation snapshot does not provide data on return on invested capital (ROIC), gross margins, or operating margins. This lack of data limits the ability to compare the company's performance against industry_config preferred metrics or cohort medians. The company's revenue concentration and geographic exposure are not disclosed in the available data. Without segment or geographic breakdowns, it is not possible to assess the diversification of its revenue streams or the risks associated with regional market exposure. Growth trajectory data is also limited. The outlook for the current and next fiscal years does not include numeric deltas or revenue history, making it difficult to evaluate the company's growth potential or historical performance. Risk factors include the inability to assess liquidity risk, which could impact the company's ability to meet short-term obligations. The dilution risk is currently low, as there is no evidence of dilutive instruments or recent equity issuances that would affect shareholder value. Recent events, such as filings or transcripts, are not available in the provided data, which limits the ability to analyze the company's strategic direction or operational developments in the near term.

30-day price · IVN(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyIvision Tech SpA
TickerIVN.MI
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. (unavailable from LLM output)

Classification. (unavailable from LLM output)

Ivision Tech SpA has a fully diluted share count of 7,912,406 shares, with no difference between basic and diluted shares outstanding, indicating no dilution from stock options or convertible securities. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability and return metrics are not available for Ivision Tech SpA, as the valuation snapshot does not provide data on return on invested capital (ROIC), gross margins, or operating margins. This lack of data limits the ability to compare the company's performance against industry_config preferred metrics or cohort medians. The company's revenue concentration and geographic exposure are not disclosed in the available data. Without segment or geographic breakdowns, it is not possible to assess the diversification of its revenue streams or the risks associated with regional market exposure. Growth trajectory data is also limited. The outlook for the current and next fiscal years does not include numeric deltas or revenue history, making it difficult to evaluate the company's growth potential or historical performance. Risk factors include the inability to assess liquidity risk, which could impact the company's ability to meet short-term obligations. The dilution risk is currently low, as there is no evidence of dilutive instruments or recent equity issuances that would affect shareholder value. Recent events, such as filings or transcripts, are not available in the provided data, which limits the ability to analyze the company's strategic direction or operational developments in the near term.
Key takeaways
  • Ivision Tech SpA has no difference between basic and diluted shares outstanding, indicating no dilution from stock options or convertible securities.
  • Liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.
  • Profitability and return metrics are not available, limiting the ability to compare the company's performance against industry benchmarks.
  • Revenue concentration and geographic exposure are not disclosed, making it difficult to assess diversification and regional market risks.
  • Growth trajectory data is limited, with no numeric deltas or revenue history provided for the current or next fiscal years.
  • Recent events, such as filings or transcripts, are not available, limiting the ability to analyze the company's strategic direction or operational developments.
  • --
  • **RATIONALES**:
Financial snapshot
PeriodHA-latest
CurrencyEUR
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4
FY-3$2.3M-$2.5k$76.5k-$973.8k
FY-2$7.9M$298.1k$282.4k$99.8k
FY-1$9.5M$483.3k$134.3k-$1.0M
FY0$15.4M$591.8k-$12.6k-$324.2k
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4
FY-3$11.7M$3.3M$208.7k
FY-2$13.8M$4.0M$752.9k
FY-1$25.5M$6.6M$2.3M
FY0$33.9M$9.8M$3.5M
PeriodOCFCapExFCFSBC
FY-4
FY-3-$2.9M-$1.9M-$973.8k
FY-2-$318.9k-$1.2M$99.8k
FY-1$823.9k-$2.7M-$1.0M
FY0$3.3M-$2.6M-$324.2k
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 369 companies
MetricIVNActivity
Op margin3.9% medp25 -31.3% · p75 14.4%
Net margin2.4% medp25 -30.5% · p75 11.1%
Gross margin46.7% medp25 28.2% · p75 63.1%
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-4.8% medp25 -11.6% · p75 -2.4%
Debt / equity17.9% medp25 2.7% · p75 52.2%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-02 03:40 UTC#66ad8f46
Market quoteclose EUR 1.69 · shares 0.01B diluted
no public URL
2026-05-02 03:40 UTC#8af8af1f
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 06:17 UTCJob: 56bb8d3e